Nanopharmaceutics, Inc. is a clinical-stage specialty pharmaceutical company developing oral, topical, and injectable products for cancer, central nervous system (CNS) disorders, and infectious diseases. Leveraging its expertise in nanoparticle and fine-particle formulations, which can specifically be used to improve hard-to-deliver BCS category II and IV drugs, Nanopharmaceutics is focused on formulation development aimed at improving drug absorption and stability.
View Top Employees from Nanopharmaceutics, Inc.| Website | http://www.nanopharmaceutics.com/ |
| Revenue | $1 million |
| Employees | View employees |
| Founded | 2018 |
| Address | 14120 NW 126th Terrace, Alachua, Florida 32615, US |
| Industry | Pharmaceutical Manufacturing, Drug Manufacturing & Research, Pharmaceuticals, Healthcare |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies |
Looking for a particular Nanopharmaceutics, Inc. employee's phone or email?
Nanopharmaceutics, Inc. Questions
The Nanopharmaceutics, Inc. annual revenue was $1 million in 2023.
Nanopharmaceutics, Inc. is based in Alachua, Florida.
The NAICS codes for Nanopharmaceutics, Inc. are [32, 3254, 32541, 325].
The SIC codes for Nanopharmaceutics, Inc. are [283, 28].
Related Companies
